166. Management of the HIV-Transplant Patient
Saturday, October 5, 2013: 10:30 AM-12:00 PM
Room: The Moscone Center: 135 (Hall E)
Co-organized with the Society of Infectious Diseases Pharmacists

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • list the majority drug interactions between HIV and transplant medications
  • describe the currently accepted listing criteria for HIV-positive patients to undergo solid-organ transplantation
  • describe the outcomes of hematopoietic cell transplantation in HIV-infected patients

Target Audience: scientists, researchers, pharmacists, nurses, investigators, infectious diseases physicians, HIV specialists, HIV clinicians, fellows, clinicians, academicians

Tracks: HIV-STD-TB, Adult ID

Moderators:  Emily Blumberg, MD, FIDSA, University of Pennsylvania Health System and Ajit Limaye, MD, FIDSA, University of Washington


10:30 AM
Solid-Organ Transplant in HIV Patients
Emily Blumberg, MD, FIDSA

11:00 AM
Critical Drug Interactions
Rupali Jain, PharmD

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-13-079-L02-P


E. Blumberg, None

A. Limaye, None

E. Blumberg, None

R. Jain, None

C. Durand, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.